Senti Biosciences
Price & Volume
Stats
See more52W Range | $1.26-$16.94 |
Market Cap | $58.6M |
Shares Short | 177,642 |
Financials
See moreRevenue (12 Mos) | $338,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$37.5M |
Diluted EPS | -$2.87 |
News
See moreYahoo Finance • 16 days ago
Senti Biosciences GAAP EPS of -$0.69 misses by $0.12
Yahoo Finance • 16 days ago
Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December
Yahoo Finance • 26 days ago
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025
Yahoo Finance • last month
Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference
About
CEO | Dr. Timothy K. Lu M.D., Ph.D. |
Address | 2 Corporate Drive, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 34 |
